AN EXPERIENCE OF USING SIMVASTATINUM IN THE METABOLIC SYNDROME OF PATIENTS WITH CHRONIC CHOLECYSTITIS AND DIABETES MELLITUS TYPE II

Authors

  • K.V. Vovk

Keywords:

simvastatinum, metabolic syndrome, chronic cholecystitis, diabetes mellitus

Abstract

The combined pathology of the internal organs at present time is the issue of the day in therapy.

The aim of the work: to define the influence of simvastatinum on the index of the lipid spectrum of the blood serum of patients with chronic cholecystitis (CC) and diabetes mellitus (DM) type II. The patients with CC and DM type II, in comparison with patients only with CC, have dislipidemia, which is characterized by: hypercholesterolemia, hypertriglyceridemia, increase of the low density and very low density lipoprotein cholesterol index, and the reduction of the high density lipoprotein cholesterol index.

The treatment of patients with both, CC and DM type II, using simvastatinum in doses of 20 mg/day result the normalization of the lipid spectrum of blood serum indexes, and may be used both as prophylaxis of the metabolic syndrome, and as treatment of patients of this category.

Downloads

Issue

No. 14 (2007)

Section

Clinical research

License

The Journal of V. N. Karazin Kharkiv National University, series Medicine has following copyright terms:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work, with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

How to Cite

AN EXPERIENCE OF USING SIMVASTATINUM IN THE METABOLIC SYNDROME OF PATIENTS WITH CHRONIC CHOLECYSTITIS AND DIABETES MELLITUS TYPE II. (2015). The Journal of V. N. Karazin Kharkiv National University, Series "Medicine", 14, 84-90. https://periodicals.karazin.ua/medicine/article/view/7043

Most read articles by the same author(s)